Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
SAN DIEGO, Oct. 23 /PRNewswire/ -- Pfizer Inc announced today that its La Jolla campus will close on Wednesday to allow the site's 1,000 scientists and staff to cope with San Diego County's ongoing fire emergency. Determination on further closures will depend upon day-to-day analysis of inform...BioMarin Announces Second Quarter 2009 Financial Results
...ses of $8.8 million associated with the La jolla Pharmaceutical Company transaction. ** Represents impairment losses on investments in La jolla Pharmaceutical Company of $4.5 million and... agreements with Summit Corporation plc and La jolla Pharmaceutical Company in 2008 and 2009, ...Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle
...attendee, we were overwhelmed at the response." states the seminars keynote speaker, Surrogacy Lawyer Theresa M. Erickson. " La jolla IVF , a premier fertility clinic located in La Jolla, California and Conceptual Options, San Diego's largest surrogacy and egg donation center are pro...Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9
..., one-by-one, nose-to-tail, with the goal of forming the world's longest line of surfboards. The line will start at Scripps Pier and continue down La jolla Shores beach. Survivor Beach was established in 2007 to bring members of the community together to create a symbol of support for cancer research and...Lice Removal Salon Offers San Diego an Upscale Solution to an Undesirable Problem
... Fairies. "We have successfully worked with thousands of schools, pediatricians, and parents to help minimize the spread of head lice." The La jolla location features a kid-friendly environment designed to provide a comfortable experience to both children and their families. While kids enjoy Game ...La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
Data Support Ability of Higher Doses to Further Reduce Antibodies to Double-Stranded DNA SAN DIEGO, March 08, 2007 /PRNewswire-FirstCall/ -- La Jolla Pharmaceutical Company today announced positive interim antibody results from its ongoing double-blind, placebo-controlled randomized Phase 3 trial ...La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial
SAN DIEGO, March 20, 2007 /PRNewswire-FirstCall/ -- La Jolla Pharmaceutical Company today announced updated interim antibody reduction data for the Phase 3 trial of Riquent(R) (abetimus sodium), its drug candidate for systemic lupus erythematosus ("lupus" or "SLE"). The updated analyses reinforce ...Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
...Lipolysis Using 1064nm, 1320nm and a Combined 1064/1320nm MultiPlex Device," Katrina E. Woodhall, Raminder Saluja, Jane Khoury, Mitchel P. Goldman, La jolla Spa MD, La Jolla, California About ASLMS The American Society for Laser Medicine and Surgery is the world's largest scientific ...La Jolla Institute discovers novel tumor suppressor
SAN DIEGO (August 3, 2009) La Jolla Institute for Allergy & Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma...La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
SAN DIEGO (February 25, 2009) A major asthma discovery by a researcher at the La Jolla Institute for Allergy & Immunology has been licensed by MedImmune, a leading innovation-focused biotechnology company and wholly owned subsidiary of AstraZeneca PLC. MedImmune licensed the discovery to explore...Toward cheap underwater sensor nets
... learn what protocols we use. Once they are certified, the volunteers go out and help us do the surveys," said Benson, who will oversee a survey in La jolla Cove on May 30. "I have the field experience, and I see the need for the cheap sensor networks we are working on," said Benson, who envisions a fu...Scripps research team identifies key molecules that inhibit viral production
...initial levels. "After we'd finished our work, we learned that Frank Chisari one of the leading experts on HCV who works at Scripps Research in La jolla had been looking at similar peptides using a very different approach," said Strosberg. "One of his peptides was the same as ours it also inhibited v...The structure of the Mre11 protein bound to DNA
...so of PBD, helped develop and is in charge of the SAXS facility. The Scripps Institute's Williams was sometimes able to work by remote control from La jolla using the advanced automation at the SIBYLS end station, whose robots and software can load samples, track ongoing experiments in real time, and colle...LIAI launches new division to look at novel approaches to heart disease and inflammation
...ntly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease. "The ...JDRF announces 2008 Scholar Award recipients
... University of California San Francisco Project: Molecular Principles of Beta Cell Differentiation and Regeneration Dr. Matthias von Herrath La jolla Institute for Allergy & Immunology Project: Live Imaging of Islet Destruction Dr. Anjana Rao Harvard Medical School Project: Manipulating T C...LIAI researchers discover new cellular mechanism that will significantly advance vaccine development
... SAN DIEGO (June 16, 2008) La jolla Institute for Allergy & Immunology (LIAI) scientists have discovered one for the textbooks. Their finding, reported Friday in the scientific journal ...72 new members chosen by Academy
...University, Bloomington KAY, STEVE A.; Dean and Richard C. Atkinson Chair, division of biological sciences, University of California, San Diego, La jolla KESSLER, RONALD C.; professor, department of health care policy, Harvard Medical School, Boston KOTTAK, CONRAD P.; Julian H. Steward Collegiate ...NIH selects LIAI for major study on allergy molecular causes and possible treatments
...GO (November 13, 2007) A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract. The five-year study, funded by the National Institute of Allergy and I...La Jolla Institute for Allergy & Immunology Wows With New Website
LOS ANGELES, April 11 /PRNewswire/ -- Specto Design (http://www.spectodesign.com ), a leading Los Angeles branding and web design company has reinvented the website for a world renowned biomedical research institute. (http://www.liai.org ) "This is a great example of how to open up the c...Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
... announced today that Dr. Tong Xu has been appointed Vice President of Process Chemistry Services. Prior to joining Sundia, Dr. Xu worked at La jolla Pharmaceutical Company, an R&D based biotech company in San Diego, USA for 12 years. At La Jolla Pharmaceutical Company, Dr. Xu rose through the ...BioMarin Announces First Quarter 2009 Financial Results
...rth quarter of 2008. Impairment Loss on La jolla Pharmaceutical Company and Summit Corporation Inve...4.5 million related to its equity investment in La jolla Pharmaceutical Company. The remaining investments...llion in Summit Corporation and $1.8 million in La jolla Pharmaceutical are reflected on the balance sheet ...BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
...ctual sales of Aldurazyme, Naglazyme and Kuvan; Merck Serono's activities related to Kuvan; the results of the final analysis of the ASPEN trial by La jolla Pharmaceuticals; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the fact...BioAtom Inc. To Present at BIOCOM Investor Conference 2008
...ay that it will present at the 3rd annual BIOCOM Investor Conference on Tuesday, October 28, 2008 at 2:30 PM PDT (5:30 PM EDT) at the Hyatt Regency La jolla in San Diego, California. Myron Karasik, M.B.A., C.M.C., Director of Finance, will present an overview of Medical Division of BioAtom Inc. of Costa ...Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
...ate overview on Tuesday, October 28, 2008 at 9:30am Pacific Time (12:30pm Eastern Time) during the BIOCOM Investor Conference at the Hyatt Aventine La jolla Hotel in San Diego. The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadenceph...Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
...hat it will present at the 3rd annual BIOCOM Investor Conference on Monday, October 27, 2008 at 11:30 a.m. PDT (2:30 p.m. EDT) at the Hyatt Regency La jolla in San Diego, California. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will present an overview of Anadys and its three cl...Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
...d overseeing all aspects of oncology research. While at Pfizer, Dr. O'Connor also built and oversaw the diabetes and obesity research groups at the La jolla campus. His managerial duties encompassed the generation of new drug targets, the selection of development candidates, and strategic and scientific su...